Orthofix to Participate in the 37th Annual Roth Conference

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent global medical technology firm, has announced its participation in the 37th Annual Roth Conference to be held in Dana Point, California. The company’s management team is scheduled to present on Monday, March 17, 2025, at 8:00 AM Pacific Time. For those interested, the presentation will be accessible via a live and archived webcast on the “Events & Presentations” section of the Orthofix investor relations website, ensuring that investors have the opportunity to stay informed.

Orthofix emphasizes the importance of maintaining open communication with its investors. The company routinely posts critical updates and information relevant to its stakeholders in the “Investors” segment of its website, encouraging both current and potential investors to visit it regularly for the latest insights about the company’s operations and trajectory.

Headquartered in Lewisville, Texas, Orthofix specializes in medical technologies aimed at healing musculoskeletal conditions. The company has a diverse range of offerings, including spinal hardware, bone growth therapies, orthopedic solutions, biologics, and innovative technologies such as the 7D FLASH™ navigation system. Orthofix is committed to providing transformative solutions that significantly improve patient outcomes and experiences globally.

For further information regarding Orthofix and its participation in industry events like the Roth Conference, stakeholders may contact Julie Dewey, the Chief Investor Relations & Communications Officer, via email or phone. Overall, Orthofix continues to engage actively with the investment community, reinforcing its position as a leader in the medical technology space.

Orthofix Medical Inc. (NASDAQ: OFIX) is poised to capture investor interest with its participation in the 37th Annual Roth Conference scheduled for March 17, 2025, at 8:00 am PT. This event is a significant platform for the company to communicate its growth strategies, product innovations, and market positioning to a broad audience, including prospective investors.

As a global medical technology company specializing in musculoskeletal solutions, Orthofix's diverse product portfolio—ranging from spinal hardware to advanced biologics—aligns well with the increasing demand for innovative healthcare solutions. The company's emphasis on healing and improving the quality of life for patients underscores its commitment to creating substantial value in the competitive healthcare market.

Given the anticipated focus on the 7D FLASH™ navigation system during the conference, investors should consider the potential implications of advancements in orthopedic technologies. As the healthcare landscape evolves, Orthofix's cutting-edge solutions may enhance surgical outcomes and patient experiences, positioning the company favorably against its competitors.

Investors looking for exposure in the medical technology sector may find Orthofix an attractive option, particularly as it prepares to share its latest developments and future growth opportunities. The company's proactive communication strategy, including regular updates through its investor relations website, ensures stakeholders remain informed about critical milestones.

In the current market environment, characterized by increased investor scrutiny and a shift towards healthcare investments, Orthofix’s participation in the Roth Conference represents a critical opportunity to strengthen its market presence and investor relations.

For potential investors, monitoring the outcomes of this presentation and subsequent market response could provide valuable insights into Orthofix's future performance. As always, investors should conduct thorough research and consider market conditions before making investment decisions.